I see no reason to flee this name, therefore, I am not.
This does not mean that prices cannot go higher but it is a short-term warning message.
Let's check out the charts and indicators of PLAN.
They are the charts of the S&P 500 and U.S. dollar, and their patterns could influence most stocks, commodities and currencies.
They include not focusing on predicting an exact low and watching for failed bounces.
The result has been a technical breakdown in risk-asset pricing -- and the main culprit is without a doubt, the inability of Congress to compromise.
EBIX offers extensive potential gains while downside appears small.
Abbott Labs can bring back some normalcy to this country -- and the world -- with its BinaxNOW rapid antigen test along with its amazing Navica app.
We're not in full-fledged panic, but I think we might call it another giant step away from complacency and toward concern.
For investors seeking value, growth and income potential - and to sleep better at night - the utility space warrants attention.
Pfizer is a quality dividend stock that's now trading at a discount.
This is the first time since the downtrend began that it feels like a full-fledged bear market and not just a rolling correction, but there are some bright spots.
With Fed's toolbox emptied and a big stimulus package unlikely, here's what I see for the economy, credit markets, and ... yes, stocks.
The greedy are, at last, getting blown out, and the prudent being vindicated. I see three buckets of stocks that intrigue me now.
We've entered no man's land as we head toward the downhill slope of the week.
Aggressive selling has been going on for months.
What would I do with the stocks? NKE is a terrific story, and TSLA's run into Battery Day has to be burned off, and it will.
Coming off Nike's strong report, Big 5 uses a strategy similar to TJX and even offers a dividend.
I don't know what's driving the fundamentals of SIRI.
The warrants are trading at a fairly heavy discount.
RL is among many companies who are trying to recreate themselves.
The pockets of strong movement are very narrow right now.
Let's review the charts and indicators.
With a month to go for these portfolios, the Active version is outperforming the Passive one, though both are crushing their Russell kindred.
RedHill Biopharma has adopted 'Veeva Vault CDMS', Veeva's modern cloud platform.
Index charts remain largely problematic.
We're seeing a period of sideways price action before renewed gains.
Beazer Homes USA and JBG Smith Properties are two names that are worth looks in the real estate sector.
The iconic retailer's shares could be in for further declines based on their technical signals.
Ant Group has passed muster for a Shanghai IPO on the STAR Market, which soon should see its first index-tracking exchange traded funds.